27 July 2026
The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family's representation.
2 June 2026
Life Healthcare Expansion Plans include adding beds, new labs, and specialists as the group targets higher occupancy across its SA network.
25 May 2026
Netcare CEO Transition sees Melanie Da Costa named CEO-designate from June 2026, succeeding Dr Richard Friedland as CEO from January 2027.
10 March 2026
Discover how AfroCentric results indicate strong revenue growth while navigating a R1.27bn loss through strategic changes.
25 November 2025
Discover how digitisation drives Netcare’s growth, reflected in increased revenue and dividends despite economic challenges.
13 November 2025
Explore how Sanlam's strategic patience with AfroCentric transforms market neglect into a promising opportunity in healthcare.
4 November 2025
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
4 November 2025
15 October 2025
Shareholders have approved the Adcock Ingram takeover by Natco Pharma, marking a new chapter for the pharmaceutical company.
16 September 2025
Ascendis to delist from the JSE as part of its strategy to go private, aiming for operational freedom and agility.
11 September 2025
Discovery Group's strong growth delivers a 30% profit surge in its latest results. Discovery Health’s profit grew by 7%.
4 September 2025
Understand Aspen Unlocking Value efforts as CEO Stephen Saad addresses the decline in share price and targets business improvements.